(Q73508241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

coronary artery disease

1 reference

Yariv Gerber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Uri Goldbourt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Shlomo Segev

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Dror Harats

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

18-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

Atherogenicity of triglyceride-rich lipoproteins

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Evidence that triglycerides are an independent coronary heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Association between serum apolipoprotein C(II) concentration and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Apolipoproteins C-II and C-III in peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Use of apolipoprotein parameters and endpoints in drug development and approval processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-7435%2803%2900051-3

7 January 2021

10.1016/S0091-7435(03)00051-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12799125%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference